Clinical Trials For New Therapeutics In Alzheimer’s Disease – Ensuring Ireland Is Research-Ready
Bibliographic record
Abstract
Abstract Background As Alzheimer’s disease (AD) enters a new treatment era, clinical trials are vital for patient access and aligning Ireland with global innovation. Dementia Trials Ireland (DTI), an Health Research Board (HRB) Clinical Trials Network (CTN), is building national trial capacity across pharmaceutical and non-pharmacological interventions including key studies of diverse intervention type such as EVOKE, EVOKE+ (anti-amyloid therapies), and DIAN studies (preventive approaches in genetically at-risk individuals). Despite progress, challenges persist which include our small patient population, limited specialist sites, regulatory complexity, and significant resource demands. Addressing these issues requires coordinated infrastructure development and workforce upskilling. Methods DTI’s ‘trial ready’ initiative, developed through working groups and harnessing PPI, aims to expand national dementia trial capacity and attract sponsors. Core components include a) pre-consented subtype-specific ‘trial ready’ cohorts; b) centralised feasibility support; c) an early career development programme; and d) simulation-based workforce training. DTI also engages with key national and international stakeholders and policymakers to reduce regulatory barriers and strengthen our potential for impact through international collaboration. Results Conclusion Ireland’s meaningful participation in the evolving AD research landscape depends on sustained investment in infrastructure, workforce development, and regulatory reform. DTI’s initiatives are laying the foundation for a nationally coordinated ‘trial ready’ platform. This ensures that Irish patients will benefit from early access to innovative therapies and that the country contributes to advancing global dementia care.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.009 | 0.013 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".